024720.KO Kolmar Holding
- Market cap
- KRW 290B
- P/E
- 6.2x
- P/B
- 0.43x
- ROE
- 17.8%
- Dividend yield
- 4.97%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 024720.KO undervalued?
Graham number024720.KO trades 65.6% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Kolmar Holding fundamental analysis
No fundamental analysis for Kolmar Holding yet.
Kolmar Holding stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Kolmar Holding
Kolmar Holdings Co.,Ltd. manufactures and sells cosmetics, pharmaceuticals, and health functional foods in South Korea and internationally. It offers skin care, color makeup, hair care, body care, and baby products, as well as functional cosmetics and perfumes. The company also provides quasi-drugs and health supplements. The company was formerly known as Kolmar Korea Holdings Co., Ltd. Kolmar Holdings Co.,Ltd. was founded in 1990 and is headquartered in Sejong City, South K…
Full company profileKolmar Holding financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Kolmar Holding annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 330B | 491B | 562B | 593B | 675B | 674B | 650B | 637B | 677B | 630B | 589B |
| Gross Profit | 81.1B | 108B | 132B | 138B | 150B | 142B | 110B | 100B | 112B | 112B | 121B |
| Operating Income | 48.7B | 61.8B | 83.5B | 93.0B | 106B | 82.4B | 42.5B | 19.1B | 17.5B | 15.3B | 37.5B |
| EBITDA | - | 84.4B | 129B | 115B | 259B | 114B | 68.6B | 41.6B | 80.7B | 55.1B | 198B |
| Net Income | 36.6B | 28.0B | 62.7B | 43.6B | 113B | 21.8B | -6.09B | -3.72B | 24.6B | 23.4B | 119B |
| EPS | - | 1,683 | 3,513 | 2,444 | 6,122 | 1,181 | -165 | -101 | 716 | 683 | 3,467 |
| Balance Sheet | |||||||||||
| Total Assets | 568B | 747B | 882B | 1.10T | 1.22T | 1.21T | 1.27T | 1.29T | 1.29T | 1.29T | 1.29T |
| Total Liabilities | 248B | 355B | 386B | 491B | 431B | 355B | 419B | 474B | 476B | 487B | 412B |
| Shareholders' Equity | 253B | 294B | 381B | 448B | 585B | 623B | 618B | 599B | 601B | 615B | 668B |
| Cash & Short-term Investments | 26.6B | 50.9B | 69.8B | 103B | 198B | 114B | 109B | 60.5B | 71.2B | 108B | 115B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 25.3B | 68.3B | 38.5B | 84.1B | 83.3B | 15.3B | -11.3B | 43.9B | 39.5B | 31.0B | 26.1B |
| Capital Expenditure | 13.8B | 29.6B | 34.1B | 82.0B | 4.03B | 57.6B | 37.5B | 86.3B | 50.6B | 24.1B | 12.2B |
| Free Cash Flow | - | 49.0B | 18.8B | 31.0B | 30.5B | -39.9B | -48.8B | -42.4B | -11.1B | 6.94B | 13.9B |
| Ratios | |||||||||||
| ROE | 14.5% | 9.5% | 16.4% | 9.7% | 19.3% | 3.5% | -1.0% | -0.6% | 4.1% | 3.8% | 17.8% |
| ROA | 6.5% | 3.8% | 7.1% | 4.0% | 9.3% | 1.8% | -0.5% | -0.3% | 1.9% | 1.8% | 9.2% |
| Net Profit Margin | 11.1% | 5.7% | 11.2% | 7.3% | 16.7% | 3.2% | -0.9% | -0.6% | 3.6% | 3.7% | 20.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Kolmar Holding dividends
- Dividend yield
- 4.97%
- Forward dividend
- 220.00 KRW
- Payout ratio
- 61.5%
- Ex-dividend date
- Mar 26, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 14.4B | 420 | 61.5% |
| 2024 | KRW 11.5B | 335 | 46.8% |
| 2023 | KRW 17.9B | 487 | - |
| 2022 | KRW 11.0B | 297 | - |
| 2021 | KRW 8.95B | 484 | 41.0% |
| 2020 | KRW 7.64B | 413 | 6.7% |
| 2019 | KRW 6.42B | 360 | 14.7% |
| 2018 | KRW 5.75B | 322 | 9.2% |
| 2017 | KRW 4.26B | 256 | 15.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Oct 19, 2023.
Who owns Kolmar Holding
- Insiders 61.97%
- Institutions 2.74%
- Public & others 35.29%
- Shares outstanding 34.3M
- Free float 11.1M
Kolmar Holding company profile
- Company name
- Kolmar Holding
- Ticker
- 024720.KO
- ISIN
- KR7024720005
- Exchange
- Korea Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 118
- Fiscal year end
- December
- Address
- 12-11 Doekgogae-gil, Sejong City, South Korea
- Phone
- 82 4 4860 0532
- Website
- kolmarholdings.co.kr
About Kolmar Holding
Kolmar Holdings Co.,Ltd. manufactures and sells cosmetics, pharmaceuticals, and health functional foods in South Korea and internationally. It offers skin care, color makeup, hair care, body care, and baby products, as well as functional cosmetics and perfumes. The company also provides quasi-drugs and health supplements. The company was formerly known as Kolmar Korea Holdings Co., Ltd. Kolmar Holdings Co.,Ltd. was founded in 1990 and is headquartered in Sejong City, South Korea.
Kolmar Holding management
1- Mr. Sang-Hyun YoonCEO & Director · born 1974